$32.20
arrow_drop_up4.20%Key Stats | |
---|---|
Open | $30.80 |
Prev. Close | $30.91 |
EPS | -2.98 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 30.65 | 32.76 |
52 Week Range | 4.80 | 34.84 |
Ratios | |
---|---|
EPS | -2.98 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
ALERTA PARA LOS ACCIONISTAS: Morris Kandinov investiga a CareDx, Inc., Puerto Rico Residents Tax-Free Fund, Inc., Puerto Rico Residents Tax-Free Fund VI, Inc., y Tax Free Fund for Puerto Rico Residents, Inc.; se anima a los accionistas a ponerse en contacto con la firma
SHAREHOLDER ALERT: Morris Kandinov Investigating CareDx, Inc., Puerto Rico Residents Tax-Free Fund, Inc., Puerto Rico Residents Tax-Free Fund VI, Inc., and Tax Free Fund for Puerto Rico Residents, Inc.; Shareholders are Encouraged to Contact the Firm
Liquid Biopsy Market to Reach $ 32.54 Billion, Globally, by 2033 at 11.61% CAGR: The Brainy Insights
Laboratory-Developed Tests (LDTs) World Market Forecast Report to 2028, with Coverage of the Effects of the FDA's New "Medical Devices: Laboratory Developed Tests" Rule, Passed in April 2024
Where CareDx Stands With Analysts - Benzinga
Decoding 6 Analyst Evaluations For CareDx